{"Symbol": "DHR", "AssetType": "Common Stock", "Name": "Danaher Corporation", "Description": "Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.", "CIK": "313616", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DIAGNOSTICS & RESEARCH", "Address": "2200 PENNSYLVANIA AVENUE N.W., WASHINGTON, DC, UNITED STATES, 20037-1701", "OfficialSite": "https://www.danaher.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "150272803000", "EBITDA": "7137000000", "PERatio": "42.18", "PEGRatio": "1.997", "BookValue": "74.32", "DividendPerShare": "1.28", "DividendYield": "0.006", "EPS": "5.04", "RevenuePerShareTTM": "34.47", "ProfitMargin": "0.147", "OperatingMarginTTM": "0.222", "ReturnOnAssetsTTM": "0.0364", "ReturnOnEquityTTM": "0.0705", "RevenueTTM": "24568001000", "GrossProfitTTM": "14523000000", "DilutedEPSTTM": "5.04", "QuarterlyEarningsGrowthYOY": "0.125", "QuarterlyRevenueGrowthYOY": "0.046", "AnalystTargetPrice": "264.86", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "18", "AnalystRatingHold": "3", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "42.18", "ForwardPE": "25.19", "PriceToSalesRatioTTM": "6.12", "PriceToBookRatio": "2.861", "EVToRevenue": "6.68", "EVToEBITDA": "23.62", "Beta": "0.958", "52WeekHigh": "242.8", "52WeekLow": "170.19", "50DayMovingAverage": "228.34", "200DayMovingAverage": "209.33", "SharesOutstanding": "706900000", "SharesFloat": "629523000", "PercentInsiders": "11.059", "PercentInstitutions": "83.577", "DividendDate": "2026-01-30", "ExDividendDate": "2025-12-26"}